共 74 条
[1]
Ataseven B(2016)FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited Gynecol Oncol 48 1476-1483
[2]
Chiva LM(2012)Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor Eur J Cancer (Oxford, England: 1990) 131 S111-S122
[3]
Harter P(2015)Cancer of the ovary, fallopian tube, and peritoneum Int J Gynaecol Obstet 105 1818-1824
[4]
Gonzalez-Martin A(2011)Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers Br J Cancer 20 1248-1259
[5]
du Bois A(2002)Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 130 493-498
[6]
Bamias A(2013)Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis Gynecol Oncol 88 134-143
[7]
Berek JS(2013)Tu-be or not tu-be: that is the question… about serous ovarian carcinogenesis Crit Rev Oncol Hematol 115 1234-1244
[8]
Crum C(2009)Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO) Cancer 136 E359-E386
[9]
Friedlander M(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 142 458-464
[10]
Braicu EI(2016)Serous ovarian and primary peritoneal cancers: a comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome Gynecol Oncol 33 2675-2682